Literature DB >> 25935273

Surgical marking pen dye inhibits saphenous vein cell proliferation and migration in saphenous vein graft tissue.

Shinsuke Kikuchi1, Richard D Kenagy2, Lu Gao3, Thomas N Wight4, Nobuyoshi Azuma5, Michael Sobel6, Alexander W Clowes3.   

Abstract

OBJECTIVE: Markers containing dyes such as crystal violet (CAS 548-62-9) are routinely used on the adventitia of vein bypass grafts to avoid twisting during placement. Because little is known about how these dyes affect vein graft healing and function, we determined the effect of crystal violet on cell migration and proliferation, which are responses to injury after grafting.
METHODS: Fresh human saphenous veins were obtained as residual specimens from leg bypass surgeries. Portions of the vein that had been surgically marked with crystal violet were analyzed separately from those that had no dye marking. In the laboratory, they were split into easily dissected inner and outer layers after removal of endothelium. This cleavage plane was within the circular muscle layer of the media. Cell migration from explants was measured daily as either (1) percentage of migration-positive explants, which exclusively measures migration, or (2) number of cells on the plastic surrounding each explant, which measures migration plus proliferation. Cell proliferation and apoptosis (Ki67 and TUNEL staining, respectively) were determined in dye-marked and unmarked areas of cultured vein rings. The dose-dependent effects of crystal violet were measured for cell migration from explants as well as for proliferation, migration, and death of cultured outer layer cells. Dye was extracted from explants with ethanol and quantified by spectrophotometry.
RESULTS: There was significantly less cell migration from visibly blue compared with unstained outer layer explants by both methods. There was no significant difference in migration from inner layer explants adjacent to blue-stained or unstained sections of vein because dye did not penetrate to the inner layer. Ki67 staining of vein in organ culture, which is a measure of proliferation, progressively increased up to 6 days in nonblue outer layer and was abolished in the blue outer layer. Evidence of apoptosis (TUNEL staining) was present throughout the wall and not different in blue-stained and unstained vein wall segments. Blue outer layer explants had 65.9 ± 8.0 ng dye/explant compared with 2.1 ± 1.3 for nonblue outer layer explants. Dye applied in vitro to either outer or inner layer explants dose dependently inhibited migration (IC50∼10 ng/explant). The IC50s of crystal violet for outer layer cell proliferation and migration were 0.1 and 1.2 μg/mL, whereas the EC50 for death was between 1 and 10 μg/mL.
CONCLUSIONS: Crystal violet inhibits venous cell migration and proliferation, indicating that alternative methods should be considered for marking vein grafts.
Copyright © 2016 Society for Vascular Surgery. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25935273      PMCID: PMC4627895          DOI: 10.1016/j.jvs.2014.10.017

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  34 in total

Review 1.  Contribution of adventitial fibroblasts to neointima formation and vascular remodeling: from innocent bystander to active participant.

Authors:  S Sartore; A Chiavegato; E Faggin; R Franch; M Puato; S Ausoni; P Pauletto
Journal:  Circ Res       Date:  2001-12-07       Impact factor: 17.367

2.  A possible role of initial cell death due to mechanical stretch in the regulation of subsequent cell proliferation in experimental vein grafts.

Authors:  S Q Liu; Y Y Ruan; D Tang; Y C Li; J Goldman; L Zhong
Journal:  Biomech Model Mechanobiol       Date:  2002-06

3.  Interaction of crystal violet with nucleic acids.

Authors:  L P Wakelin; A Adams; C Hunter; M J Waring
Journal:  Biochemistry       Date:  1981-09-29       Impact factor: 3.162

4.  In situ saphenous vein bypass.

Authors:  J E Connolly; J H Kwaan
Journal:  Arch Surg       Date:  1982-12

5.  Early remodeling of saphenous vein grafts: proliferation, migration and apoptosis of adventitial and medial cells occur simultaneously with changes in graft diameter and blood flow.

Authors:  M Kalra; V M Miller
Journal:  J Vasc Res       Date:  2000 Nov-Dec       Impact factor: 1.934

6.  Graft-extrinsic cells predominate in vein graft arterialization.

Authors:  Lisheng Zhang; Neil J Freedman; Leigh Brian; Karsten Peppel
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-01-15       Impact factor: 8.311

7.  Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice.

Authors:  Yanhua Hu; Zhongyi Zhang; Evelyn Torsney; Ali R Afzal; Fergus Davison; Bernhard Metzler; Qingbo Xu
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

8.  Both donor and recipient origins of smooth muscle cells in vein graft atherosclerotic lesions.

Authors:  Yanhua Hu; Manuel Mayr; Bernhard Metzler; Martin Erdel; Fergus Davison; Qingbo Xu
Journal:  Circ Res       Date:  2002-10-04       Impact factor: 17.367

9.  External collar inhibits balloon-induced intimal hyperplasia in rabbits.

Authors:  Per Fogelstrand; Bo Risberg; Erney Mattsson
Journal:  J Vasc Res       Date:  2002 Jul-Aug       Impact factor: 1.934

10.  Beta-galactosidase-tagged adventitial myofibroblasts tracked to the neointima in healing rat vein grafts.

Authors:  Jeffrey J Tomas; V Emily Stark; Jimmy L Kim; Randal A Wolff; Debra A Hullett; Thomas F Warner; John R Hoch
Journal:  J Vasc Res       Date:  2003 May-Jun       Impact factor: 1.934

View more
  4 in total

1.  A single nucleotide polymorphism of cyclin-dependent kinase inhibitor 1B (p27Kip1) associated with human vein graft failure affects growth of human venous adventitial cells but not smooth muscle cells.

Authors:  Richard D Kenagy; Shinsuke Kikuchi; Lihua Chen; Errol S Wijelath; Andrew B Stergachis; John Stamatoyannopoulos; Gale L Tang; Alexander W Clowes; Michael Sobel
Journal:  J Vasc Surg       Date:  2017-05-16       Impact factor: 4.268

2.  Clinical factors that influence the cellular responses of saphenous veins used for arterial bypass.

Authors:  Michael Sobel; Shinsuke Kikuchi; Lihua Chen; Gale L Tang; Tom N Wight; Richard D Kenagy
Journal:  J Vasc Surg       Date:  2018-06-15       Impact factor: 4.268

Review 3.  Improving the Outcome of Vein Grafts: Should Vascular Surgeons Turn Veins into Arteries?

Authors:  Toshihiko Isaji; Takuya Hashimoto; Kota Yamamoto; Jeans M Santana; Bogdan Yatsula; Haidi Hu; Hualong Bai; Guo Jianming; Tambudzai Kudze; Toshiya Nishibe; Alan Dardik
Journal:  Ann Vasc Dis       Date:  2017-03-31

4.  Versican is differentially regulated in the adventitial and medial layers of human vein grafts.

Authors:  Richard D Kenagy; Shinsuke Kikuchi; Steve P Evanko; Matthijs S Ruiter; Marco Piola; Alban Longchamp; Maurizio Pesce; Monica Soncini; Sébastien Deglise; Gianfranco B Fiore; Jacques-Antoine Haefliger; Tannin A Schmidt; Mark W Majesky; Michael Sobel; Thomas N Wight
Journal:  PLoS One       Date:  2018-09-28       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.